AZN — AstraZeneca PLC stock price and chart

AZN

AstraZeneca PLCStock · Health CareMSCI EAFE 1.4% · MSCI World 0.3% · MSCI ACWI 0.3% · Nasdaq Composite 0.0000%

$168.10+1.22%

as of market close, Sep 21, 2026

☾ AH $168.10 +0.00%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDSD

20162019202120242026

60.080.0100.0120.0140.0160.0180.0200.0050.0M100.0M$168.10

2026-09-21

Price$168.10

MA20$176.86

MA50$176.00

Vol13.7M

What would $1,000 invested in AZN be worth today? →

AZN returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $168.10
Change YTD: -8.57%
Next earnings: Nov 5, 2026
52W low: $145.80
52W high: $212.71
From 52W high: -20.97%
From 52W low: +15.29%
52W range: 33%
Beta: 0.26

Volume

Rel volume: 0.89×
30D volume: 3.3M
30D $ vol: 535.9M

Fundamentals

EPS (ttm): $6.542015-12 $2.232025-12 $6.54+193.3% over the window
FCF (ttm): 14.6B
Net margin: 17.42%2015-12 11.4%2025-12 17.4%+52.3% over the window
ROE: 21.03%2015-12 15.3%2025-12 21.0%+37.6% over the window
ROA: 8.97%2015-12 4.7%2025-12 9.0%+90.6% over the window
Debt / equity: 0.51×2015-12 0.762025-12 0.51-33.6% over the window
Current ratio: 0.942015-12 1.082025-12 0.94-12.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.64%2024-12-31 → 2025-12-3154.1B → 58.7B (+8.6% total)+9.82%2022-12-31 → 2025-12-3144.4B → 58.7B (+32.4% total)+17.16%2020-12-31 → 2025-12-3126.6B → 58.7B (+120.7% total)+9.04%2015-12-31 → 2025-12-3124.7B → 58.7B (+137.7% total)
Net income: +45.37%2024-12-31 → 2025-12-317B → 10.2B (+45.3% total)+45.91%2022-12-31 → 2025-12-313.3B → 10.2B (+210.8% total)+26.62%2020-12-31 → 2025-12-313.1B → 10.2B (+225.5% total)+13.73%2015-12-31 → 2025-12-312.8B → 10.2B (+262.1% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +45.37%2024-12-31 → 2025-12-31$4.50 → $6.54 (+45.3% total)+45.79%2022-12-31 → 2025-12-31$2.11 → $6.54 (+210.0% total)+21.80%2020-12-31 → 2025-12-31$2.44 → $6.54 (+168.0% total)+11.36%2015-12-31 → 2025-12-31$2.23 → $6.54 (+193.3% total)
Dividend/share: +5.39%2024-12-31 → 2025-12-31$2.97 → $3.13 (+5.4% total)+2.58%2022-12-31 → 2025-12-31$2.90 → $3.13 (+7.9% total)+2.25%2020-12-31 → 2025-12-31$2.80 → $3.13 (+11.8% total)+1.13%2015-12-31 → 2025-12-31$2.80 → $3.13 (+11.9% total)
Price: +8.48%2025-09-22 → 2026-09-21$155.00 → $168.10 (+8.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.84%2023-09-21 → 2026-09-21$134.04 → $168.10 (+25.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+7.29%2021-09-21 → 2026-09-21$118.26 → $168.10 (+42.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.58%2016-09-20 → 2026-09-21$67.30 → $168.10 (+149.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +9.62%2025-09-22 → 2026-09-21$153.40 → $168.10 (+9.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.75%2023-09-21 → 2026-09-21$127.14 → $168.10 (+32.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.40%2021-09-21 → 2026-09-21$107.30 → $168.10 (+56.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.62%2016-09-20 → 2026-09-21$51.23 → $168.10 (+228.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 25.7×2016-09 29.472026-09 25.70-12.8% over the window
Fwd P/E: 14.3×
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 1.86%
Dividend/share (fwd): $3.13

Vs own 10Y history

P/E: 13th

Bar = where today’s multiple sits in AZN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-21

+1.22%

+2.64%

+1.28%

-3.90%

YTD

-8.57%

+10.19%

+42.14%

Financial statements

Open full AZN financials →

Loading financial statements…

Ticker	Name	1M	1D
NVS	Novartis AG	-11.26%	+0.43%
NVO	Novo Nordisk A/S	-14.85%	-7.96%
GSK	GSK plc American Depositary Shares (Each representing two Ordinary Shares)	-2.54%	+1.71%
SNY	Sanofi ADS	-7.31%	+0.05%
ARGX	argenx SE American Depositary Shares	-4.96%	-0.21%
TAK	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	+3.91%	-0.11%
NTRA	Natera Inc.	+11.63%	+0.34%
TEVA	Teva Pharmaceutical Industries Limited American Depositary Shares	+7.28%	+2.77%

AstraZeneca PLC (AZN) trades at $168.10 with a live price and an interactive chart covering 17+ years of daily price history, plus key valuation metrics. ChartRow also publishes AZN’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full AZN financial statements →

AZN — AstraZeneca PLC price, chart and key statistics